• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助手术在接受化疗后腹膜后淋巴结清扫术的睾丸癌患者中的应用。

Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.

机构信息

Department of Urology, Norris Cancer Center, University of Southern California, Los Angeles, CA, USA.

出版信息

Ann Surg Oncol. 2012 Jul;19(7):2388-93. doi: 10.1245/s10434-012-2284-8. Epub 2012 Mar 7.

DOI:10.1245/s10434-012-2284-8
PMID:22395993
Abstract

PURPOSE

To evaluate the clinicopathologic characteristics of patients undergoing adjuvant surgery during postchemotherapy retroperitoneal lymph node dissection (PC-RPLND).

METHODS

From 2004 to 2010, 85 testicular cancer patients underwent PC-RPLND by a single surgeon (S.D.). A bilateral template approach was utilized with nerve-sparing technique whenever feasible. The clinicopathologic and outcome of patients who underwent removal of any organ or structure during PC-RPLND were reviewed.

RESULTS

Of 85 patients undergoing PC-RPLND, 28 (33%) required adjuvant procedures. Thirteen (15%) required vascular procedures including cavotomy/caval resection in 6, aortic resection in 8, common iliac vessels resection in 4, and renal vessels resection/reimplant in 2. Twelve patients (14%) required adjuvant nephrectomy (ten of 12 left-sided). There was one ureteral resection with appendiceal substitution, one partial duodenectomy, two cholecystectomy, two thoracotomies, four liver resection/biopsy, and one neck dissection. There were eight early complications (28%), including vocal cord paralysis, brachial plexus injury, lower extremities compartment syndrome, thigh numbness, upper gastrointestinal bleeding, retroperitoneal hematoma, and alcohol withdrawal. No perioperative death was reported. Retroperitoneal pathology revealed mature teratoma in 11 patients (39%), fibrosis in 8 (28%), and viable germ cell tumor (GCT) in 9 (32%). A total of 75, 82, and 66% of patients with fibrosis, teratoma, and viable GCT, respectively, had no evidence of recurrence at a mean follow-up of 18 months.

CONCLUSIONS

Many patients undergoing PC-RPLND require adjuvant surgery, including vascular procedures and nephrectomy. The excellent outcomes associated with low operative morbidity and mortality validates such aggressive surgical approaches performed by experienced surgeons.

摘要

目的

评估化疗后腹膜后淋巴结清扫术(PC-RPLND)期间接受辅助手术的患者的临床病理特征。

方法

2004 年至 2010 年,由一位外科医生(S.D.)对 85 例睾丸癌患者进行了 PC-RPLND。只要可行,就采用双侧模板方法和神经保留技术。回顾了在 PC-RPLND 过程中切除任何器官或结构的患者的临床病理和结果。

结果

在 85 例接受 PC-RPLND 的患者中,有 28 例(33%)需要辅助手术。13 例(15%)需要血管手术,包括 6 例腔静脉切开/切除术、8 例主动脉切除术、4 例髂总血管切除术和 2 例肾血管切除术/再植术。12 例(14%)患者需要辅助性肾切除术(12 例中有 10 例为左侧)。有 1 例输尿管切除术伴阑尾替代术、1 例部分十二指肠切除术、2 例胆囊切除术、2 例开胸术、4 例肝切除术/活检术和 1 例颈部清扫术。有 8 例早期并发症(28%),包括声带麻痹、臂丛神经损伤、下肢间隔综合征、大腿麻木、上消化道出血、腹膜后血肿和酒精戒断。无围手术期死亡报告。腹膜后病理学显示 11 例(39%)为成熟畸胎瘤、8 例(28%)为纤维化和 9 例(32%)为有活力的生殖细胞瘤(GCT)。纤维化、畸胎瘤和有活力的 GCT 患者的分别有 75%、82%和 66%在平均 18 个月的随访中无复发证据。

结论

许多接受 PC-RPLND 的患者需要辅助手术,包括血管手术和肾切除术。这种积极的手术方法由经验丰富的外科医生实施,具有出色的结果和较低的手术发病率和死亡率。

相似文献

1
Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.辅助手术在接受化疗后腹膜后淋巴结清扫术的睾丸癌患者中的应用。
Ann Surg Oncol. 2012 Jul;19(7):2388-93. doi: 10.1245/s10434-012-2284-8. Epub 2012 Mar 7.
2
Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.化疗后腹腔镜腹膜后淋巴结清扫术治疗低容量 II 期非精原细胞瘤生殖细胞肿瘤:前 100 例患者。
Eur Urol. 2013 Jun;63(6):1013-7. doi: 10.1016/j.eururo.2012.09.036. Epub 2012 Sep 24.
3
[Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].改良腹膜后淋巴结清扫术治疗睾丸非精原细胞性生殖细胞肿瘤的疗效
Ai Zheng. 2008 Dec;27(12):1302-6.
4
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?对于化疗后残留肿瘤,是否总是需要进行双侧完全腹膜后淋巴结清扫?
Cancer. 2007 Sep 15;110(6):1235-40. doi: 10.1002/cncr.22898.
5
Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.睾丸晚期生殖细胞肿瘤化疗后腹膜后淋巴结清扫术
Eur Urol. 2008 Feb;53(2):260-72. doi: 10.1016/j.eururo.2007.10.033. Epub 2007 Oct 31.
6
Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.接受多种化疗方案治疗转移性睾丸生殖细胞肿瘤后行腹膜后淋巴结清扫术患者的病理结果及临床结局
Cancer. 2007 Feb 1;109(3):528-35. doi: 10.1002/cncr.22440.
7
Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.晚期睾丸生殖细胞肿瘤化疗后腹膜后淋巴结清扫术:根治性或改良模板切除术。
Eur Urol. 2009 Jan;55(1):217-24. doi: 10.1016/j.eururo.2008.09.027. Epub 2008 Sep 24.
8
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.德国睾丸癌研究组进行的AUO试验AH 01/94:一项随机III期试验,比较腹膜后淋巴结清扫术与博来霉素、依托泊苷联合顺铂化疗一个疗程在临床I期非精原性睾丸生殖细胞肿瘤辅助治疗中的效果。
J Clin Oncol. 2008 Jun 20;26(18):2966-72. doi: 10.1200/JCO.2007.12.0899. Epub 2008 May 5.
9
Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.化疗后残留畸胎瘤男性患者接受腹膜后淋巴结清扫术的长期临床结局
J Clin Oncol. 2007 Mar 20;25(9):1033-7. doi: 10.1200/JCO.2005.05.4791. Epub 2007 Jan 29.
10
Retroperitoneal vascular surgery for the treatment of giant growing teratoma syndrome.腹膜后血管外科手术治疗巨大生殖细胞瘤综合征。
Urology. 2012 Feb;79(2):365-70. doi: 10.1016/j.urology.2011.08.076. Epub 2011 Dec 14.

引用本文的文献

1
Implementing High-Quality Retroperitoneal Lymph Node Dissection for Testicular Cancer at an Australian Tertiary Hospital: Challenging the Centralisation Paradigm in High-Need Areas.在澳大利亚一家三级医院实施高质量的睾丸癌腹膜后淋巴结清扫术:挑战高需求地区的集中化模式。
Res Rep Urol. 2025 Mar 10;17:59-67. doi: 10.2147/RRU.S474281. eCollection 2025.
2
Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer at a National Referral Centre.国家转诊中心针对转移性睾丸癌的化疗后腹膜后淋巴结清扫术
Cancers (Basel). 2025 Feb 11;17(4):608. doi: 10.3390/cancers17040608.
3
Survival outcomes of postchemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: A retrospective cohort study from a single tertiary center in South India.
非精原细胞性生殖细胞肿瘤化疗后腹膜后淋巴结清扫术的生存结果:来自印度南部一家单一三级中心的回顾性队列研究。
Indian J Urol. 2024 Apr-Jun;40(2):112-120. doi: 10.4103/iju.iju_456_23. Epub 2024 Apr 1.
4
Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor.在后化疗腹膜后淋巴结清扫期间为非精原细胞瘤生殖细胞肿瘤行肾下下腔静脉和腹主动脉完全血管置换。
Curr Oncol. 2023 Jun 4;30(6):5448-5455. doi: 10.3390/curroncol30060412.
5
Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341-342 of this issue: MicroRNA-371a-3p as a blood-based biomarker in testis cancer.本期第341 - 342页由本杜·K·科内、约翰·T·拉芬和阿迪蒂亚·巴格罗迪亚撰写的社论:微小RNA - 371a - 3p作为睾丸癌的血液生物标志物。
Asian J Urol. 2021 Oct;8(4):400-406. doi: 10.1016/j.ajur.2021.08.004. Epub 2021 Aug 26.
6
Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.当代睾丸癌患者化疗后腹膜后淋巴结清扫术的主要并发症及文献综述
World J Surg Oncol. 2020 Sep 24;18(1):253. doi: 10.1186/s12957-020-02032-1.
7
Primary and post-chemotherapy robotic retroperitoneal lymph node dissection for testicular cancer: a review.睾丸癌的原发性及化疗后机器人辅助腹膜后淋巴结清扫术:综述
Transl Androl Urol. 2020 Apr;9(2):949-958. doi: 10.21037/tau.2020.02.09.
8
Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitals.两家中等规模医院中转移性睾丸癌化疗后腹膜后淋巴结清扫术的额外手术操作及围手术期发病率
World J Urol. 2021 Mar;39(3):839-846. doi: 10.1007/s00345-020-03229-5. Epub 2020 May 5.
9
Surgical strategies for postchemotherapy testis cancer.化疗后睾丸癌的手术策略
Transl Androl Urol. 2020 Jan;9(Suppl 1):S74-S82. doi: 10.21037/tau.2019.09.43.
10
Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.腹膜后淋巴结清扫术治疗睾丸精原细胞瘤:基于人群的实践和生存结局。
World J Urol. 2018 Jan;36(1):73-78. doi: 10.1007/s00345-017-2099-0. Epub 2017 Oct 12.